Parkinson's Disease Treatment Guidelines 2002 issued by Societas Neurologica Japonica Kazuko Hasegawa OriginalPaper Pages: 8 - 12
Where do we stand in the treatment of Parkinson's disease? Yoshikuni Mizuno OriginalPaper Pages: 13 - 18
Initiation of symptomatic therapy in Parkinson's disease: dopamine agonists versus levodopa Nirit LevRuth DjaldettiEldad Melamed OriginalPaper Pages: 19 - 26
Management of levodopa-induced dyskinesias in Parkinson's disease Kenichi Kashihara OriginalPaper Pages: 27 - 31
Dementia in Parkinson's disease Maria J. MartíEduardo TolosaAndres de la Cerda OriginalPaper Pages: 41 - 48
Genetics of restless legs syndrome: evidence for a hereditary disorder Eng-King Tan OriginalPaper Pages: 68 - 73
Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery Mitsutoshi YamamotoTadahisa Uesugi OriginalPaper Pages: 74 - 78